To enable the investigation of late pathogenesis and drug effects on bone with COL1A1 glycine substitutions, we aimed to construct a novel OI mouse model harboring a glycine substitution in one Col1A1 allele and to evaluate the effects of 4PBA in this mouse model. The gene discussed is COL1A1; the disease is osteogenesis imperfecta.